Related Experiment Video
Updated: Jun 28, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Is pre-diabetes a predictor of events in patients with atrial fibrillation?
Ana Ledo Piñeiro1, Emad Abu-Assi1, Inmaculada González Bermúdez2
1Department of Cardiology, University Hospital Álvaro Cunqueiro, Vigo, Spain; Health Research Institute Galicia Sur, Vigo, Spain.
Insights
In patients with atrial fibrillation (AF) and pre-diabetes, elevated glycated hemoglobin (HbA1c) levels did not correlate with increased risk of ischemic or bleeding events. This study found no association between pre-diabetes ranges of HbA1c and worse prognosis in non-diabetic AF patients.
Area of Science:
- Cardiology
- Endocrinology
- Internal Medicine
Background:
- Diabetes mellitus (DM) is a known risk factor for atrial fibrillation (AF) and its associated ischemic strokes.
- Limited data exists on the association between glycated hemoglobin (HbA1c) and adverse events in patients with pre-diabetes and AF.
Purpose of the Study:
- To investigate if pre-diabetes, indicated by HbA1c levels, predicts ischemic events, bleeding events, myocardial infarction, or mortality in non-diabetic patients with AF.
Main Methods:
- A retrospective study analyzed 2993 non-diabetic AF patients, categorized into normal glucose (n=1351) and pre-diabetes (n=1642) groups based on HbA1c.
- Incidence rates per 100 person-years were compared between groups.
- Competitive hazard regression and Cox regression analyses were used to assess risks.
Main Results:
- No significant differences in incidence rates of various events were observed between the normal glucose and pre-diabetes groups.
- Analysis of HbA1c as a continuous variable also showed no association with increased event risk, even after adjusting for CHA2DS2-VASc and HAS-BLED scores.
Conclusions:
- In a cohort of 2993 non-diabetic patients with new-onset AF, pre-diabetes defined by HbA1c levels was not associated with a worse prognosis regarding ischemic or bleeding events.
Background:
Diabetes mellitus (DM) increases the probability of presenting atrial fibrillation (AF) and it is a predictor of its ischemic stroke. There is limited information of the association between glycated hemoglobin (HbA1c) levels and ischemic, embolic or bleeding events in patients with pre-DM and AF.
Methods:
To investigate whether the presence of pre-DM in patients with AF predicts ischemic or bleeding events, myocardial infarction or mortality, we performed a retrospective study with a final cohort of 2993 non-diabetic patients with AF and data of glycated hemoglobin (HbA1c). We divided the cohort in two groups: those with normal glucose (n = 1351) and those with pre-diabetes (n = 1642). Incidence rates were calculated as the number of events per 100 person-years and were then compared between groups. Competitive hazard regression analysis for non-fatal events(death as the competing event) and conventional Cox regression for mortality were performed.
Results:
There was not difference between groups for incidence rates of the different events per 100 person-years. Even considering HbA1c as continuous variable, the unadjusted analysis showed no relation between levels of HbA1c and more risk of events. This association remained not significant after adjustment for CHA2DS2-VASc score, HAS-BLED score and anticoagulation therapy.
Conclusion:
In this study of 2993 non-diabetic patients with new-onset AF, we have not found an association between HbA1c and worse prognosis when it is in the range of pre-diabetes.
More Related Videos
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Pre-Procedural Guidelines for Assessing Blood Pressure
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...

